Icon Wealth Advisors, LLC Biogen Inc. Transaction History

Icon Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $12,297 - $15,527	-58 Reduced 6.97%	774 $166,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $62,547 - $75,291	-281 Reduced 25.25%	832 $215,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $45,944 - $55,823	-182 Reduced 14.05%	1,113 $308,000
Q3 2022 Jan 25, 2023	BUY	$194.69 - $268.46 $252,123 - $347,655	1,295 New	1,295 $346,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Icon Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Icon Wealth Advisors, LLC with notifications on news.